文献速递神经肿瘤

神经肿瘤临床实践中脑肿瘤拟似病变的构成分析

The landscape of brain tumor mimics in neuro-oncology practice.
PubMed 文献 · J Neurooncol · 2022-07-20

该回顾性研究纳入2005年1月1日至2017年12月31日转诊至神经肿瘤科、初诊疑似脑肿瘤但最终符合非肿瘤性病变诊断的成人患者。脑肿瘤拟似病变的发生率为3.4%(132/3897),病因以血管性(35%)、非脱髓鞘性炎症(26%)、脱髓鞘(15%)、囊肿(10%)、感染(9%)及杂类(5%)为主;38%的患者接受活检以明确诊断,其中26%的活检结果不确定。

要点

  • 脑肿瘤拟似病变占神经肿瘤转诊的3.4%(132/3897)。
  • 血管性、炎症性和脱髓鞘性病因合计占拟似病变的三分之二。
  • 38%的患者接受活检以明确诊断,其中26%的活检结果不确定。

核心结论

  • 脑肿瘤拟似病变是神经肿瘤转诊中占比小但重要的一部分,识别其临床、影像和实验室特征可能改善资源利用并避免不必要及潜在有害的诊疗干预。

研究设计与样本

  • 回顾性研究,纳入2005年1月1日至2017年12月31日转诊至神经肿瘤科、初诊疑似脑肿瘤但最终经神经影像、临床病程和/或组织病理学评估符合非肿瘤性病变诊断的成人患者。

主要发现

  • 脑肿瘤拟似病变的发生率为3.4%(132/3897)。
  • 非肿瘤性病变的病因构成为血管性35%、非脱髓鞘性炎症26%、脱髓鞘15%、囊肿10%、感染9%、杂类5%。
  • 38%的患者接受活检以明确诊断,其中26%的活检结果不确定。

关键数值与推荐

  • 血管性、炎症性和脱髓鞘性病因合计占拟似病变的三分之二。

临床怎么用

  • 作者认为,识别此类病变的临床、影像和实验室特征可能改善资源利用并避免不必要及潜在有害的诊疗干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Differentiating neoplastic and non-neoplastic brain lesions is essential to make management recommendations and convey prognosis, but the distinction between brain tumors and their mimics in practice may prove challenging. The aim of this study is to provide the incidence of brain tumor mimics in the neuro-oncology setting and describe this patient subset. METHODS: Retrospective study of adult patients referred to the Division of Neuro-oncology for a presumed diagnosis of brain tumor from January 1, 2005 through December 31, 2017, who later satisfied the diagnosis of a non-neoplastic entity based on neuroimaging, clinical course, and/or histopathology evaluation. We classified tumor mimic entities according to clinical, radiologic, and laboratory characteristics that correlated with the diagnosis. RESULTS: The incidence of brain tumor mimics was 3.4% (132/3897). The etiologies of the non-neoplastic entities were vascular (35%), inflammatory non-demyelinating (26%), demyelinating (15%), cysts (10%), infectious (9%), and miscellaneous (5%). In our study, 38% of patients underwent biopsy to determine diagnosis, but in 26%, the biopsy was inconclusive. DISCUSSION: Brain tumor mimics represent a small but important subset of the neuro-oncology referrals. Vascular, inflammatory, and demyelinating etiologies represent two-thirds of cases. Recognizing the clinical, radiologic and laboratory characteristics of such entities may improve resource utilization and prevent unnecessary as well as potentially harmful diagnostic and therapeutic interventions.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Yogendran LV, Kalelioglu T, Donahue JH, et al. The landscape of brain tumor mimics in neuro-oncology practice. J Neurooncol. 2022. PMID: 35857249. doi:10.1007/s11060-022-04087-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。